Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what plans NICE has to include guidance on treatment of recurrent ovarian cancer in its review of NICE guidelines.

The National Institute for Health and Care Excellence (NICE) has advised that its guideline on ovarian cancer (CG122) currently covers the recognition and initial management of ovarian cancer. The treatment of recurrent ovarian cancer is not covered by the current guideline’s scope.

The guideline was last considered for review in 2016 and at this stage NICE decided to update the guideline. This update may include developing recommendations specifically related to the recognition of recurrent cancer depending on the final scope, which is yet to be determined.

It is for NHS England to commission new clinical guidelines from NICE on health-related topics.